Thursday, March 14, 2019

Hot Tech Stocks For 2019

tags:IDTI,LXFT,AVGO,KYO,

Looking to invest in precious metals? Streaming companies may be the way to go. Instead of mining metals themselves, streaming companies essentially lend to miners -- but instead of collecting interest, streamers receive part of the mine's future output at a steep discount. It's a great business model that allows streamers to both diversify revenue streams and seize unique opportunities.

The largest streaming company in the world (by revenue, not market capitalization) is Wheaton Precious Metals (NYSE:WPM). Wheaton began as a silver streaming company in 2004 under the name Silver Wheaton, but the company began seeing opportunities in gold around 2013, and in 2017 it changed its name to Wheaton Precious Metals to signify its diversification.

Just last week the company started a new chapter, announcing its first streaming deal in a third metal: cobalt.

A bet on... electric vehicles?

"I've owned a Tesla (NASDAQ:TSLA) for five years and I will never own a gas vehicle again." That's a quote not from Al Gore or Elon Musk, but rather Wheaton CEO Randy Smallwood. His decision to stream cobalt is exactly that: a bet on EV adoption. It's also a bet that cobalt, which currently plays an important role in today's EV batteries and will continue to be an important component of future battery technology.

Hot Tech Stocks For 2019: Integrated Device Technology, Inc.(IDTI)

Advisors' Opinion:
  • [By Shane Hupp]

    Segall Bryant & Hamill LLC lessened its position in shares of Integrated Device Technology (NASDAQ:IDTI) by 12.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,764,874 shares of the semiconductor company’s stock after selling 257,440 shares during the quarter. Integrated Device Technology comprises 1.2% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 16th biggest holding. Segall Bryant & Hamill LLC’s holdings in Integrated Device Technology were worth $53,935,000 at the end of the most recent quarter.

  • [By Dan Caplinger]

    The stock market had an up-and-down day on Tuesday, with most major market benchmarks losing ground in the morning only to rebound later in the session. Early concerns about trade seemed to weigh on market sentiment, but positive news on the economic front, plus advances for some leading technology companies helped get stocks moving back in the right direction. Moreover, some company-specific news from key players across multiple sectors also lifted investors' spirits. Sonic (NASDAQ:SONC), Integrated Device Technology (NASDAQ:IDTI), and Casey's General Store (NASDAQ:CASY) were among the best performers on the day. Below, we'll look more closely at these companies to tell you why their stocks did so well.

  • [By Shane Hupp]

    Integrated Device Technology (NASDAQ:IDTI) last posted its quarterly earnings results on Monday, April 30th. The semiconductor company reported $0.46 EPS for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.02. The business had revenue of $224.60 million for the quarter, compared to analysts’ expectations of $222.20 million. Integrated Device Technology had a positive return on equity of 23.10% and a negative net margin of 1.44%. The business’s quarterly revenue was up 27.8% on a year-over-year basis. During the same period last year, the firm earned $0.35 earnings per share. sell-side analysts anticipate that Integrated Device Technology Inc will post 1.44 earnings per share for the current fiscal year.

Hot Tech Stocks For 2019: Luxoft Holding, Inc.(LXFT)

Advisors' Opinion:
  • [By Shane Hupp]

    Formula Growth Ltd. bought a new position in Luxoft Holding Inc (NYSE:LXFT) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 52,000 shares of the software maker’s stock, valued at approximately $1,916,000. Formula Growth Ltd. owned about 0.15% of Luxoft at the end of the most recent reporting period.

  • [By Garrett Baldwin]

    By submitting your email address you will receive a free subscription to Profit Alerts and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

    Three Stocks to Watch Today: CSCO, M, BLK The earnings report calendar is headlined today by Cisco Systems Inc. (Nasdaq: CSCO). The tech giant will report fiscal fourth-quarter earnings after the bell. Wall Street expects that the firm will report earnings per share (EPS) of $0.69 on top of $12.77 billion in revenue. Shares of Macy's Inc. (NYSE: M) are on the move after the company reported earnings before the bell. The iconic retailer reported adjusted EPS of $0.70 on top of $5.57 billion in revenue. Wall Street had expected EPS of $0.49 on top of $5.61 billion in revenue. Shares of Macy's stock were off 5.3% in premarket hours. George Soros' firm Soros Fund Management increased its stake in shares of Blackrock Inc. (NYSE: BLK) by a whopping 60% in the second quarter, according to a U.S. Securities and Exchange Commission (SEC) filing. If you were using Money Morning's proprietary Stock VQScore™, you'd have known that Blackrock was sitting in the "Buy Zone" before the SEC filing was made public. The global asset manager has a perfect 4.75 score, and it will look to blast off now that other investors start to follow Soros and other institutional investors that love this stock. To learn more about the Money Morning Stock VQScore, go here right now. Look for additional earnings reports from NetApp Inc. (Nasdaq: NTAP), MSG Networks Inc. (NYSE: MSGN), CACI International Inc. (NYSE: CACI), Briggs & Stratton Corp. (NYSE: BGG), SpartanNash Co. (Nasdaq: SPTN), and Luxoft Holding Inc. (NYSE: LXFT).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Luxoft (LXFT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Tech Stocks For 2019: Avago Technologies Limited(AVGO)

Advisors' Opinion:
  • [By Chris Dier-Scalise]

    Strong balance sheets and consistent demand for discrete processors and GPUs across the board has kept the likes of Micron and semi-behemoth NVIDIA trucking past the rest of the market, both posting top and bottom line revenue results for seven consecutive quarters. Other companies like Intel and Qualcomm, whose processor sales rely mainly on the sales figures of PCs and devices they’re included in, have also surged ahead as market leaders. Intel Corporation (NASDAQ: INTC) posted record annual revenue over the course of  2017 and both Intel and Qualcomm remain leading candidates in the M&A game despite the block of latter’s deal with Broadcom Ltd. (NASDAQ: AVGO).

  • [By Chris Lange]

    Broadcom Inc. (NASDAQ: AVGO) is scheduled to release its fiscal second-quarter financial results after the markets close on Thursday. The consensus estimates call for $4.76 in earnings per share (EPS) and $5.0 billion in revenue. The same period of last year had $3.69 in EPS and $4.2 billion in revenue.

  • [By Ashraf Eassa]

    Earlier this year, in the midst of the drama surrounding Broadcom's (NASDAQ:AVGO) attempted takeover of Qualcomm, Jacobs relinquished his role as chairman but stayed on as a director. Then, shortly after rumors began to surface that he was trying to take Qualcomm private, Jacobs was kicked off the board of directors.

  • [By Paul Ausick]

    To say that Broadcom Ltd. (NASDAQ: AVGO) reacted badly Tuesday when Qualcomm Inc. (NASDAQ: QCOM) raised its offer for NXP Semiconductors Inc. (NASDAQ: NXPI) probably would be an understatement. Broadcom had last week sweetened its hostile bid for Qualcomm on the condition that Qualcomm either give up on its acquisition of NXP or complete the deal at the existing offer of $110 a share.

  • [By ]

    Marvell Technology (MRVL) and Cavium (CAVM) both posted large gains on Monday, as investors wagered Marvell's $6 billion deal to buy Cavium is now less likely to be blocked by Beijing. Broadcom (AVGO) , which has bought plenty of chipmakers over the last few years and has indicated it's open to making smaller deals after seeing the Trump Administration shoot down its hostile bid for Qualcomm, also has to be pleased at the possibility that Beijing won't act as a deterrent to chip industry dealmaking going forward.

  • [By Ethan Ryder]

    Broadcom (NASDAQ:AVGO) had its target price increased by investment analysts at B. Riley from $245.00 to $250.00 in a research note issued to investors on Friday, MarketBeat reports. The firm currently has a “neutral” rating on the semiconductor manufacturer’s stock. B. Riley’s price target would indicate a potential upside of 7.49% from the stock’s previous close.

Hot Tech Stocks For 2019: Kyocera Corporation(KYO)

Advisors' Opinion:
  • [By Logan Wallace]

    Media stories about Kyocera (NYSE:KYO) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kyocera earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the electronics maker an impact score of 44.7168933477613 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Shane Hupp]

    Taiwan Semiconductor Mfg. (NYSE:TSM) and Kyocera (NYSE:KYO) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

  • [By Max Byerly]

    Media coverage about Kyocera (NYSE:KYO) has trended somewhat positive on Monday, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Kyocera earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave news articles about the electronics maker an impact score of 44.4825472854626 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Anders Bylund]

    Shares of Japanese materials giant Kyocera (NYSE:KYO) gained 12.1% in April 2018, according to data from S&P Global Market Intelligence. The stock rode a strong fourth-quarter report to these gains despite zero coverage in the financial press.

Zynerba Pharmaceuticals (ZYNE) Trading Up 5.1% Following Earnings Beat

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)’s share price was up 5.1% during trading on Tuesday following a better than expected earnings announcement. The stock traded as high as $5.14 and last traded at $5.11. Approximately 736,648 shares traded hands during mid-day trading, a decline of 30% from the average daily volume of 1,048,403 shares. The stock had previously closed at $4.86.

The company reported ($0.44) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.65) by $0.21. The business had revenue of $0.09 million for the quarter.

Get Zynerba Pharmaceuticals alerts:

A number of research firms have weighed in on ZYNE. ValuEngine downgraded Zynerba Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Cantor Fitzgerald set a $21.00 target price on Zynerba Pharmaceuticals and gave the stock a “buy” rating in a research report on Wednesday, December 5th. Zacks Investment Research downgraded Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Sunday, January 27th. Finally, HC Wainwright set a $23.00 target price on Zynerba Pharmaceuticals and gave the stock a “buy” rating in a research report on Tuesday, November 13th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $13.38.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc raised its position in Zynerba Pharmaceuticals by 23.8% in the third quarter. Vanguard Group Inc now owns 651,400 shares of the company’s stock worth $5,316,000 after purchasing an additional 125,327 shares in the last quarter. Virtu Financial LLC bought a new position in Zynerba Pharmaceuticals in the fourth quarter valued at approximately $40,000. Zeke Capital Advisors LLC bought a new position in Zynerba Pharmaceuticals in the third quarter valued at approximately $193,000. Vanguard Group Inc. boosted its stake in Zynerba Pharmaceuticals by 23.8% in the third quarter. Vanguard Group Inc. now owns 651,400 shares of the company’s stock valued at $5,316,000 after acquiring an additional 125,327 shares during the last quarter. Finally, Thompson Siegel & Walmsley LLC bought a new position in shares of Zynerba Pharmaceuticals during the third quarter worth $157,000. Institutional investors and hedge funds own 16.40% of the company’s stock.

The stock has a market capitalization of $85.67 million, a price-to-earnings ratio of -2.06 and a beta of 4.98.

TRADEMARK VIOLATION NOTICE: “Zynerba Pharmaceuticals (ZYNE) Trading Up 5.1% Following Earnings Beat” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4216494/zynerba-pharmaceuticals-zyne-trading-up-5-1-following-earnings-beat.html.

About Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Zynerba Pharmaceuticals, Inc operates as a clinical stage specialty pharmaceutical company. The company focuses on developing and commercializing pharmaceutically-produced transdermal cannabinoid treatments for rare or near-rare neuropsychiatric disorders. Its product candidates include ZYN002, which completed Phase II clinical trial for pediatric and adolescent patients with fragile X syndrome, pediatric and adolescent patients with developmental and epileptic encephalopathies, and adult patients with refractory epileptic focal seizures; and ZYN001 that is in Phase I clinical trial to treat Tourette syndrome.

Featured Story: Diversification For Individual Investors

Tuesday, March 12, 2019

Upbeat on private banks, auto and cement sector: Kim Eng Securities

Jigar Shah, CEO of Kim Eng Securities India, in an interview with CNBC-TV18 shared his views on the market fundamentals and select stocks.

"The rally seems to be driven on the back of the immediate announcement and excitement, with the narrative being more towards the return of current government to power," said Shah.

"The market valuations are not cheap, earnings growth is tardy, plus macro data is not encouraging and domestic flows are a bit down, so one is not sure if the current market rally would be sustainable, but if current narrative becomes stronger then the market could touch previous highs or go higher," he added.

According to Shah, the key aspect of earnings and fundamentals would return after elections, "which will decide the trajectory for market and equity return in the second half".

The house is upbeat on private banks, auto and cement sector.

Source: CNBC-TV18 First Published on Mar 12, 2019 02:19 pm

Monday, March 11, 2019

Why Frontier Communications Stock Jumped 52.5% in February

What happened

Shares of Frontier Communications (NASDAQ:FTR) stock rose 52.5%% in February, according to data from S&P Global Market Intelligence. Despite last month's big gains, the stock is down roughly 67% over the last year.

FTR Chart

FTR data by YCharts.

Frontier Communications has been hit hard by the cord-cutting that's reshaping the pay-TV industry, and the business' weak performance growth outlook has been reflected by its stock performance over the last several years. However, the company's fourth-quarter earnings report arrived with a rare bit of sunshine and triggered big stock gains.

A person pointing a remote at a television.

Image source: Getty Images.

So what

The average analyst estimate called for Frontier to post $209 million in sales for its December quarter, but actual results surpassed that target -- coming in at $212 million. While its commercial segment once again posted declining sales, its consumer segment actually managed to boost sales -- largely thanks to an increase in revenue per customer. Overall sales for the quarter were down roughly 4.5% year over year but were flat sequentially.

The company reported a net loss of $219 million for the quarter and an adjusted per-share loss of $0.06 compared to the $0.04 loss per share target called for by the average analyst estimate. That might not sound like the type of performance that typically results in substantial stock gains, but Frontier stock had seen such dramatic losses that shares rebounded when the company managed to deliver flat sequential revenue. 

Now what

Frontier stock has given up some of its big February gains this month, with shares trading down 11.8% in March so far. 

FTR Chart

FTR data by YCharts.

The fourth-quarter revenue beat was a welcome change, and there may be signs that the business is stabilizing, but Frontier's path to long-term growth continues to look challenging. The company's heavy exposure to the cable industry and comparatively weak position in the broadband service offerings that are softening the cord-cutting blow for other telecoms continues to be an issue. The business may be seeing some positive customer-retention trends, but it still looks like pricing hikes and operating expense reductions are Frontier's best shot at a turnaround.